A Proactive Approach to Detecting Cancer: Penn State Health St. Joseph Cancer Center’s Cancer Risk Evaluation Program
Penn State Health St. Joseph Cancer Center uses genetic evaluation to determine patients’ cancer risk and provide actionable next steps through their Cancer Risk Evaluation Program (CREP).
Penn State Cancer Institute Researchers Promote Personalized Colorectal Cancer Screening in Central Pennsylvania
Colorectal cancer is the second-leading cause of cancer death in central Pennsylvania, which is partially attributable to low screening rates among certain segments of the population. Penn State Cancer Institute researchers are developing and testing strategies to improve screening rates in order to diagnose and treat colorectal cancer in earlier stages, when treatment efficacy is generally optimized.
Penn State Health Medical Group — Andrews Patel Hematology/Oncology: Greater Collaboration in Cancer Care Benefits Patients
Andrews Patel Hematology/Oncology has been providing central Pennsylvania residents access to high-level cancer care for more than 30 years and is now doing even more as part of Penn State Health.
True to its rich history of innovation, Penn State Heart and Vascular Institute at Penn State Health Milton S. Hershey Medical Center offers advanced therapies available only through clinical trials — treatments in the vanguard of care that can improve quality of life while laying the groundwork to help untold numbers of patients enjoy a brighter future.
Treatment of skull base tumors, including those affecting the pituitary gland, traditionally entailed opening the skull or making large incisions in the face and removing parts of the facial bones. These invasive procedures caused significant pain and scarring and required long hospital stays.
- 1 of 16
- next ›